Bloomberg News

Human Genome Sciences Sparks Bullish Call Options

April 19, 2012

Bloomberg's Dominic Chu reports that call options for Human Genome Sciences jumped after the company received and declined an unsolicited buy offer from GlaxoSmithKline and announced that it is putting itself up for sale. He speaks on Bloomberg Television's "InBusiness With Margaret Brennan." (Source: Bloomberg)

Running Time: 02:23

Coke's Big Fat Problem

(enter your email)
(enter up to 5 email addresses, separated by commas)

Max 250 characters

blog comments powered by Disqus